Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand

2006826 citationsJournal Articlebronze Open Access

Authors

Despite the successful completion of this efficacy trial, the vaccine did not prevent HIV-1 infection or delay HIV-1 disease progression.

Good health and well-being

Published in: The Journal of Infectious Diseases

Volume 194, Issue 12, pp. 1661-1671

Field-Weighted Citation Impact: 11.23